Giant left atrium

Same author

The Neutrophil-NET Axis in Immune Checkpoint Inhibitor Resistance in Non-Small Cell Lung Cancer: Roles, Biomarkers and Therapeutic Opportunities.

Biomolecules·2026

Same author

Intraoperative vascular ligation uncovers the role of tumor vasculature in Doege-Potter syndrome: a case report.

Frontiers in oncology·2026

Same author

Integrated Transcriptomic and Proteomic Analysis of the Stress Response Mechanisms of <i>Micractinium</i> from the Tibetan Plateau Under Leather Wastewater Exposure.

Biology·2026

Same author

Novel FAK inhibitors suppress tumor growth and reverse EGFR-TKI resistance in non-small cell lung cancer.

Cancer drug resistance (Alhambra, Calif.)·2025

Same author

Ibrutinib combined with rituximab and high-dose methotrexate in newly diagnosed primary CNS diffuse large B-cell lymphoma: a pilot study with long-term follow-up.

Frontiers in oncology·2025

Same author

CDK7 as a New therapeutic target in pancreatic and lung cancer: current evidence and future perspectives.

Expert opinion on therapeutic targets·2025

Same journal

The surgical collateralization theory: has the beautiful hypothesis been killed by the ugly facts?

European heart journal·2026

Same journal

Beyond single measurement: additional considerations for high-sensitivity C-reactive protein in cardiovascular risk prediction.

European heart journal·2026

Same journal

Brain mineralocorticoid receptor activation and antagonism in heart failure with preserved ejection fraction: a hypothesis.

European heart journal·2026

Same journal

Myths and misconceptions about high-sensitivity C-reactive protein as a marker of residual inflammatory risk.

European heart journal·2026

Same journal

Vascular Ehlers-Danlos syndrome: should we treat asymptomatic patients?

European heart journal·2026

Same journal

Impactful trials on dyslipidaemias, fractional flow reserve, beta-blockers, and peripheral artery disease.

European heart journal·2026

Related Experiment Videos

Giant left atrium

Related Concept Videos

The Neutrophil-NET Axis in Immune Checkpoint Inhibitor Resistance in Non-Small Cell Lung Cancer: Roles, Biomarkers and Therapeutic Opportunities.

Intraoperative vascular ligation uncovers the role of tumor vasculature in Doege-Potter syndrome: a case report.

Integrated Transcriptomic and Proteomic Analysis of the Stress Response Mechanisms of <i>Micractinium</i> from the Tibetan Plateau Under Leather Wastewater Exposure.

Novel FAK inhibitors suppress tumor growth and reverse EGFR-TKI resistance in non-small cell lung cancer.

Ibrutinib combined with rituximab and high-dose methotrexate in newly diagnosed primary CNS diffuse large B-cell lymphoma: a pilot study with long-term follow-up.

CDK7 as a New therapeutic target in pancreatic and lung cancer: current evidence and future perspectives.

The surgical collateralization theory: has the beautiful hypothesis been killed by the ugly facts?

Beyond single measurement: additional considerations for high-sensitivity C-reactive protein in cardiovascular risk prediction.

Brain mineralocorticoid receptor activation and antagonism in heart failure with preserved ejection fraction: a hypothesis.

Myths and misconceptions about high-sensitivity C-reactive protein as a marker of residual inflammatory risk.

Vascular Ehlers-Danlos syndrome: should we treat asymptomatic patients?

Impactful trials on dyslipidaemias, fractional flow reserve, beta-blockers, and peripheral artery disease.

Related Experiment Videos

Giant left atrium

Related Concept Videos

Related Articles

The Neutrophil-NET Axis in Immune Checkpoint Inhibitor Resistance in Non-Small Cell Lung Cancer: Roles, Biomarkers and Therapeutic Opportunities.

Intraoperative vascular ligation uncovers the role of tumor vasculature in Doege-Potter syndrome: a case report.

Integrated Transcriptomic and Proteomic Analysis of the Stress Response Mechanisms of <i>Micractinium</i> from the Tibetan Plateau Under Leather Wastewater Exposure.

Novel FAK inhibitors suppress tumor growth and reverse EGFR-TKI resistance in non-small cell lung cancer.

Ibrutinib combined with rituximab and high-dose methotrexate in newly diagnosed primary CNS diffuse large B-cell lymphoma: a pilot study with long-term follow-up.

CDK7 as a New therapeutic target in pancreatic and lung cancer: current evidence and future perspectives.

The surgical collateralization theory: has the beautiful hypothesis been killed by the ugly facts?

Beyond single measurement: additional considerations for high-sensitivity C-reactive protein in cardiovascular risk prediction.

Brain mineralocorticoid receptor activation and antagonism in heart failure with preserved ejection fraction: a hypothesis.

Myths and misconceptions about high-sensitivity C-reactive protein as a marker of residual inflammatory risk.

Vascular Ehlers-Danlos syndrome: should we treat asymptomatic patients?

Impactful trials on dyslipidaemias, fractional flow reserve, beta-blockers, and peripheral artery disease.